Amphora, produced by Evofem Inc., was approved by the FDA in 2004 as a personal lubricant.
Since then, various testings on Amphora have showed promise as a non-hormonal contraceptive gel through its ability to immobilize sperm. It has potential to be effective for up to 8-10 hours prior to intercourse and may even prevent certain sexually transmitted infections.
The Amphora contraceptive clinical trial began in April 2011 and will be completed in 2014. The trial is testing Amphora's efficacy in preventing pregnancy compared to the FDA-approved vaginal gel, Conceptrol®.
Amphora gel lines the vaginal canal, and uses lactic acid to help maintain the vagina's natural acidic pH level. By balancing the natural pH level, Amphora creates an opposing environment for sperm, inhibiting the ability to migrate to the cervix, and thus preventing conception.
Upon successful completion of the trial in 2014, Evofem Inc. plans to introduce Amphora as a non-hormonal, latex-free and inexpensive over-the-counter contraceptive for women.
Sexual health expert Dr. Lisa Oldson, MD, reveals the development of the new contraceptive, its effectiveness and if the birth control option is a safe choice for you.